Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 26;15(6):e41002.
doi: 10.7759/cureus.41002. eCollection 2023 Jun.

Cardiac Manifestations of Sjogren's Syndrome: A Review of Literature

Affiliations
Review

Cardiac Manifestations of Sjogren's Syndrome: A Review of Literature

Larabe Farrukh et al. Cureus. .

Abstract

Sjogren's syndrome (SS) is a chronic inflammatory disorder of the exocrine glands. It is characterized by a lymphocytic infiltrate in the lacrimal and salivary glands causing keratoconjunctivitis sicca and xerostomia. Extra-glandular involvement may be present in about one-third of patients with primary Sjogren's syndrome (pSS). The most commonly affected organs are the thyroid, lungs, gastrointestinal tract, kidneys, skin, and nervous system. Cardiac manifestations of Sjogren's syndrome are rare and not well-described in the current literature. Most of the evidence is present in the form of case reports and small case series. However, recent studies have shown that patients with Sjogren's syndrome (SS) seem to have a greater overall risk of cardiovascular (CV) events. Although not conventionally considered a feature of the disease, cardiac manifestations can lead to increased morbidity and mortality in this patient population. In this review article, we study the association between cardiac diseases and primary Sjogren's syndrome.

Keywords: adults; atrioventricular heart block; autoimmune disease; cardiac manifestation; primary sjogren syndrome (pss).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Severe reversible cardiomyopathy in primary Sjögren's syndrome. Caballero-Güetoa J. Rev Esp Cardiol. 2007;60:326–327. - PubMed
    1. Cardiovascular risk in patients with Sjogren’s syndrome. Garcia A, Trevisani VFM, Dardin LP, Milani PA, Czapkowski A. https://ard.bmj.com/content/74/Suppl_2/1082.3 BMJ. 2015;74:1082–1083.
    1. Cardiovascular disease in primary Sjögren’s syndrome: raising clinicians’ awareness. Casian M, Jurcut C, Dima A, Mihai A, Stanciu S, Jurcut R. Front Immunol. 2022;13:865373. - PMC - PubMed
    1. Serum lipid levels in Sjögren's syndrome. Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Rheumatology (Oxford) 2006;45:481–484. - PubMed
    1. Precocious intima-media thickening in patients with primary Sjögren's syndrome. Vaudo G, Bocci EB, Shoenfeld Y, et al. Arthritis Rheum. 2005;52:3890–3897. - PubMed

LinkOut - more resources